Vizient conducts first Insight: Cell, Gene, and Specialty Pharmacy Symposium
Fortune Media and Great Place To Work Name Vizient to ‘100 Best Companies to Work For’ in 2024
LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
Vizient Announces Acquisition of PrefTech OR, a Next-generation Physician Preference Card Management Technology
Vizient Recognizes 22 Suppliers and Distributors for Service Excellence
IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announced the publication of its first public report on care utilization and quality using data from Medicare's Data Sharing for Performance Measurement, also known as the Qualified Entity Program (QEP). The report, “Measuring Care Utilization and Quality for Those with Chronic Kidney Disease by Payer and Community Vulnerability,” evaluates the cost and quality of care provided to patients with chronic kidney disease (CKD) and end stage renal disease (ESRD) by payer, based on four indicators of resource use and quality and also explores outcomes through the lens of high social need communities using the patent pending Vizient Vulnerability IndexTM.
Vizient Releases 2022 Diversity, Equity and Inclusion (DEI) Report
Vizient: Lack of Information Across Supply Chain Exacerbating Oncology Drug Shortage
IRVING, Texas--(BUSINESS WIRE)--Yesterday on Capitol Hill, Vizient, Inc. hosted a policy briefing titled, “Beyond the Four Walls: How Hospitals are Addressing Social Determinants of Health,” at the Rayburn House Office Building. Featuring remarks by Representatives Terri Sewell (D-AL) and Dwight Evans (D-PA), and sponsored by Representative Jake Ellzey (R-TX), the event, attended by more than 70 congressional staff and industry stakeholders, focused on how hospitals are actively addressing the external factors that impact community health.